Insider · CIK 0001573429

Pauls Matthew

Reports to the SEC for 7 companies · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001573429

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-02	PTHSPelthos Therapeutics Inc.S Sale	Director	SSale	−786 sh	$21.00	−$16.5K	13,578
2026-07-02	PTHSPelthos Therapeutics Inc.S Sale	Director	SSale	−692 sh	$26.00	−$18K	14,458
2026-07-02	PTHSPelthos Therapeutics Inc.S Sale	Director	SSale	−94 sh	$27.36	−$2,571.878	14,364
2026-06-29	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2026-05-18	SOLENO THERAPEUTICS INCD Disposition to Issuer	Director	DDisposition to Issuer	−10.5K sh	—	—	0
2026-05-18	SOLENO THERAPEUTICS INCStock Option (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,063 sh	—	—	0
2026-04-02	PTHSPelthos Therapeutics Inc.S Sale	Director	SSale	−415 sh	$20.52	−$8,513.891	15,521
2026-04-02	PTHSPelthos Therapeutics Inc.S Sale	Director	SSale	−371 sh	$21.36	−$7,925.599	15,150
2025-12-16	SVRASavara IncG Gift	Director, CHIEF EXECUTIVE OFFICER	GGift	−129K sh	—	—	1,188,050
2025-12-14	SVRASavara IncF Tax Payment	Director, CHIEF EXECUTIVE OFFICER	FTax Payment	−196K sh	$6.92	−$1.35M	1,317,045
2025-12-10	SVRASavara IncG Gift	Director, CHIEF EXECUTIVE OFFICER	GGift	−23.6K sh	—	—	1,512,750
2025-12-10	PTHSPelthos Therapeutics Inc.G Gift	Director	GGift	−9,542 sh	—	—	1,074
2025-10-02	PTHSPelthos Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,123 sh	—	—	10,616
2025-10-02	PTHSPelthos Therapeutics Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,123 sh	—	—	14,862
2025-07-02	PTHSPelthos Therapeutics Inc. · Restricted Stock UnitsA Award	Director	AAward	+25.5K sh	—	—	25,478
2025-07-02	PTHSPelthos Therapeutics Inc. · Stock OptionA Award	Director	AAward	+77.6K sh	—	—	77,640
2025-07-02	PTHSPelthos Therapeutics Inc.A Award	Director	AAward	+25.5K sh	—	—	25,478
2025-07-02	PTHSPelthos Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+8,493 sh	—	—	8,493
2025-07-02	PTHSPelthos Therapeutics Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−8,493 sh	—	—	16,985
2025-06-05	SOLENO THERAPEUTICS INCA Award	Director	AAward	+3,991 sh	—	—	10,491
2025-03-28	SOLENO THERAPEUTICS INCM Exercise/Conversion	Director	MExercise/Conversion	+5,937 sh	$4.60	+$27.3K	12,437
2025-03-28	SOLENO THERAPEUTICS INCS Sale	Director	SSale	−5,937 sh	$71.55	−$425K	6,500
2025-03-28	SOLENO THERAPEUTICS INCEmployee stock option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,937 sh	—	—	9,063
2024-12-16	SVRASavara IncS Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−54.7K sh	$3.31	−$181K	1,536,379
2024-12-13	SVRASavara IncF Tax Payment	Director, CHIEF EXECUTIVE OFFICER	FTax Payment	−92.6K sh	$3.21	−$297K	1,591,081
2024-12-12	SVRASavara IncA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+400K sh	—	—	1,683,674
2024-12-12	SVRASavara Inc · Stock Option (Right to Buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+900K sh	—	—	900,000
2024-06-06	SOLENO THERAPEUTICS INCA Award	Director	AAward	+6,500 sh	—	—	6,500
2023-12-28	SVRASavara IncS Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−84K sh	$4.71	−$396K	1,302,674
2023-12-28	SVRASavara IncG Gift	Director, CHIEF EXECUTIVE OFFICER	GGift	−19K sh	—	—	1,283,674
2023-12-14	SVRASavara IncF Tax Payment	Director, CHIEF EXECUTIVE OFFICER	FTax Payment	−110K sh	$4.45	−$488K	936,674
2023-12-14	SVRASavara IncA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+450K sh	—	—	1,386,674
2023-12-14	SVRASavara Inc · Stock Option (Right to Buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+225K sh	—	—	225,000
2023-08-15	SOLENO THERAPEUTICS INCStock option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2022-12-13	SVRASavara IncA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+325K sh	—	—	1,046,354
2022-12-13	SVRASavara Inc · Stock Option (Right to Buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+700K sh	—	—	700,000
2021-12-31	SVRASavara IncF Tax Payment	Director, CHIEF EXECUTIVE OFFICER	FTax Payment	−62.3K sh	$1.24	−$77.3K	721,354
2021-12-14	SVRASavara IncA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+400K sh	—	—	783,672
2021-12-14	SVRASavara Inc · Stock Option (Right to Buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+350K sh	—	—	350,000
2021-12-08	SVRASavara IncP Purchase	Director, CHIEF EXECUTIVE OFFICER	PPurchase	+6,500 sh	$1.06	+$6,889.35	383,672
2021-12-02	SVRASavara IncP Purchase	Director, CHIEF EXECUTIVE OFFICER	PPurchase	+10K sh	$1.10	+$11K	377,172
2021-11-19	SVRASavara IncP Purchase	Director, CHIEF EXECUTIVE OFFICER	PPurchase	+10K sh	$1.11	+$11.1K	365,022
2021-11-19	SVRASavara IncP Purchase	Director, CHIEF EXECUTIVE OFFICER	PPurchase	+2,150 sh	$1.06	+$2,289.75	367,172
2021-11-18	SVRASavara IncP Purchase	Director, CHIEF EXECUTIVE OFFICER	PPurchase	+10K sh	$1.10	+$11K	355,022
2021-08-18	SVRASavara IncP Purchase	Director, CHIEF EXECUTIVE OFFICER	PPurchase	+11.9K sh	$1.19	+$14.2K	345,022
2021-08-17	SVRASavara IncP Purchase	Director, CHIEF EXECUTIVE OFFICER	PPurchase	+15K sh	$1.18	+$17.7K	333,122
2021-05-21	SVRASavara IncP Purchase	Director, CHIEF EXECUTIVE OFFICER	PPurchase	+10K sh	$1.63	+$16.3K	318,122
2021-04-19	SVRASavara IncP Purchase	Director, CHIEF EXECUTIVE OFFICER	PPurchase	+27.4K sh	$1.82	+$49.9K	308,122
2021-03-22	SVRASavara IncP Purchase	Director, CHIEF EXECUTIVE OFFICER	PPurchase	+24.1K sh	$2.07	+$49.9K	280,722
2021-02-22	SVRASavara IncP Purchase	Director, CHIEF EXECUTIVE OFFICER	PPurchase	+28.7K sh	$1.74	+$50K	256,622

Recent filings

Accepted (ET)
Oct 64
Pauls Matthew0001919246-26-000129
SEC(opens sec.gov)
Jul 74
Pauls Matthew0001919246-26-000101
SEC(opens sec.gov)
Jul 14
Pauls Matthew0001104659-26-079865
SEC(opens sec.gov)
May 184
Pauls Matthew0001573429-26-000001
SEC(opens sec.gov)
Apr 64
Pauls Matthew0001919246-26-000053
SEC(opens sec.gov)
Apr 14/A
Pauls Matthew0001919246-26-000042
SEC(opens sec.gov)
Dec 164
Pauls Matthew0001193125-25-321185
SEC(opens sec.gov)
Dec 124
Pauls Matthew0001753926-25-001884
SEC(opens sec.gov)
Dec 114
Pauls Matthew0001193125-25-316295
SEC(opens sec.gov)
Jul 74
Pauls Matthew0001753926-25-001107
SEC(opens sec.gov)
Jun 94
Pauls Matthew0001415889-25-016358
SEC(opens sec.gov)

Companies

Address

C/O PELTHOS THERAPEUTICS INC. 4020 STIRRUP CREEK DRIVE, SUITE 110

DURHAM, NC, 27703